drugs fromin vitrodata: the effect of fluconazole on zidovudine glucuronidation. Br J
Clin Pharmacol. Forthcoming.
Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Application of the relative activity
factor approach in scaling from heterologously expressed cytochromes p450 to
human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol
Exp Ther 2001;297:326–337.
Warrington JS, Shader RI, von Moltke LL, Greenblatt DJ.In vitrobiotransformation
of sildenafil (Viagra): identification of human cytochromes and potential drug
interactions. Drug Metab Dispos 2000;28:392–397.
Williams JA, Bauman J, Cai H, Conlon K, Hansel S, Hurst S, Sadagopan N, Tugnait M,
Zhang L, Sahi J.In vitroADME phenotyping in drug discovery: current challenges and
future solutions. Curr Opin Drug Discov Devel 2005;8:78–88.
Williams JA, Hurst SI, Bauman J, Jones BC, Hyland R, Gibbs JP, Obach RS, Ball SE.
Reaction phenotyping in drug discovery: moving forward with confidence? Curr
Drug Metab 2003;4:527–534.
Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup
JR, Ball SE. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a
pharmacokinetic explanation for typically observed low exposure (AUCi/AUC)
ratios. Drug Metab Dispos 2004;32:1201–1208.
Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA.
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed
estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other
compounds to human liver microsomes. Drug Metab Dispos 2002a;30:1266–1273.
Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman
MA, Hall SD, Wrighton SA. Comparative metabolic capabilities of CYP3A4,
CYP3A5, and CYP3 A7. Drug Metab Dispos 2002b;30:883–891.
Wring SA, Silver IS, Serabjit-Singh CJ. Automated quantitative and qualitative analysis
of metabolic stability: A process for compound selection during drug discovery.
Methods Enzymol 2002;357:285–296.
Yeung CK, Lang DH, Thummel KE, Rettie AE. Immunoquantitation of FMO1 in
human liver, kidney, and intestine. Drug Metab Dispos 2000;28:1107–1111.
Zhang D, Wang L, Chandrasena G, Ma L, Zhu M, Zhang H, Davis CD, Humphreys
WG. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase
enzymes in thein vitrometabolism of muraglitazar. Drug Metab Dispos 2007;
35:139–149.
Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, Vachharajani N, Mitroka J.
Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
Drug metab dispos: the biological fate of chemicals 2005;33:500–507.
Zhu W, Song L, Zhang H, Matoney L, LeCluyse E, Yan B. Dexamethasone
differentially regulates expression of carboxylesterase genes in humans and rats.
Drug Metab Dispos 2000;28:186–191.
Ziegler DM. Recent studies on the structure and function of multisubstrate flavin-
containing monooxygenases. Annu Rev Pharmacol Toxicol 1993;33:179–199.
510 REACTION PHENOTYPING